{"adverse_reactions":["Sincerus Florida, LLC adverse reactions. x"],"components":["Active, Inactive d"],"effective_time":"20190423","id":"8738d91c-e670-0a37-e053-2991aa0a663e","instructions_for_use":["Directions for use z"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1125-2 IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / NIACINAMIDE 2%, Gel 30gm z"],"set_id":"8738d91c-e66f-0a37-e053-2991aa0a663e","spl_product_data_elements":["IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / NIACINAMIDE 2% IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / NIACINAMIDE 2% IMIQUIMOD IMIQUIMOD LEVOCETIRIZINE DIHYDROCHLORIDE LEVOCETIRIZINE NIACINAMIDE NIACINAMIDE"],"version":"1"}